1 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Seebri: new trials by email Literature Review of Seebri trials Research Report on Seebri
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ANTES B+ Clinical Trial Trelegy Ellipta 100/62.5/25Mcg Inh 30D, Brimica, Duaklir - Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | Fundacio Privada Mon Clinic Barcelona | 48 | 2024-02-29 | 2025-08-14 |
| Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge Tiotropium, glycopyrronium, Respimat - Asthma | Phase 4 | Completed | University of Saskatchewan | 13 | 2015-11-01 | 2016-04-20 |
Asthma (1) · Pulmonary Disease, Chronic Obstructive (1)
Fundacio Privada Mon Clinic Barcelona (1) · University of Saskatchewan (1)
Canada (1) · Spain (1)
2023 (1)